Your browser doesn't support javascript.
loading
Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases.
Silacci, Michela; Lembke, Wibke; Woods, Richard; Attinger-Toller, Isabella; Baenziger-Tobler, Nadja; Batey, Sarah; Santimaria, Roger; von der Bey, Ulrike; Koenig-Friedrich, Susann; Zha, Wenjuan; Schlereth, Bernd; Locher, Mathias; Bertschinger, Julian; Grabulovski, Dragan.
Afiliación
  • Silacci M; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Lembke W; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Woods R; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Attinger-Toller I; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Baenziger-Tobler N; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Batey S; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Santimaria R; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • von der Bey U; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Koenig-Friedrich S; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Zha W; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Schlereth B; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Locher M; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Bertschinger J; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
  • Grabulovski D; a Covagen AG; one of the Janssen Pharmaceutical Companies of Johnson & Johnson ; Wagistrasse 25, 8952 Schlieren , Switzerland.
MAbs ; 8(1): 141-9, 2016.
Article en En | MEDLINE | ID: mdl-26390837
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Factor de Necrosis Tumoral alfa / Interleucina-17 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: MAbs Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Factor de Necrosis Tumoral alfa / Interleucina-17 Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: MAbs Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos